Abstract
The disease entities to be considered in this review are characterized clinically by a slow but relentless deterioration of intellectual faculties resulting in profound dementia and eventually death during middle and late life. Alzheimer’s disease, Pick’s disease, Huntington’s chorea, Creutzfeldt-Jakob disease, and senile dementia are included in this group of “primary dementias” where the unifying pathologic feature is a degeneration of the cerebral cortex with varying degrees of involvement of related structures. These conditions, which as yet have no established cause (the special status of Creutzfeldt-Jakob disease is discussed below) and as far as can be determined at present are not related to any known disorder, stand in contrast to the “secondary dementias” that occur in association with syphilitic infection, cerebrovascular disease, brain tumor, myxedema, alcoholism, nutritional deficiencies, encephalitis, trauma, and chronic neurological diseases such as disseminated sclerosis, subacute combined degeneration, Wilson’s disease, and the cerebral lipidoses. These secondary dementias are considered elsewhere in this Handbook.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
J. S. Woodward, Alzheimer’s disease in late adult life, Amer. J. Path. 49: 1157–1169 (1966).
C. J. Gibbs, Jr., D. C. Gadjusek, D. M. Asher, M. P. Alpers, E. Beck, P. M. Daniel, and W. B. Matthews, Creutzfeldt-Jakob disease (spongioform encephalopathy): transmission to the chimpanzee, Science 161: 388–389 (1968).
C. J. Gibbs, Jr. and D. C. Gadjusek, Infection as the etiology of spongioform encephalopathy (Creutzfeldt-Jakob disease), Science 165: 1023–1025 (1969).
W. R. Gowers, The pathology of tabes dorsalis and general paralysis of the insane, Lancet ii:1591-1592(1899).
W. R. Gowers, A lecture on abiotrophy, Lancet i: 1003–1007 (1902).
A. Alzheimer, Über eine eigenartige erkrankung der hirnrinde, Zbl. Nervenheilk. 30: 177-179 (1907), Allg. Z. Psychiat. 64:146-148 (1907).
P. Blocq and G. Marinesco. Sur les lésions et la pathogénie de l’épilepsie dite essentielle, Sem. Méd. Paris 12: 445–446 (1892).
E. Redlich, Ueber miliare sklerose der hirnrinde bei seniler atrophie, J. Psychiat. Neurol. 17: 208–216 (1898).
F. Bonfiglio, Di speciali reperti in un caso di probabile sifilide cerebrale, Riv. Sper. Freniat. 34: 196–199 (1908).
G. Perusini, Über klinisch und histologisch eigenartige psychische erkrankungen des spateren lebensalters, Histol. Histopath. Arb. Grosshirnrinde (Jena) 3: 297–358 (1910).
U.E. Kraepelin, Psychiatrie; ein lehrbuch für studierende und aerzte Vol. 2, 8th ed., p. 624, Leipzig, J. A.Barth, 1910.
W. H. McMenemey, Alzheimer’s disease: problems concerning its concept and nature, Acta Neurol. Scand. 39: 369–380 (1963).
W. H. McMenemey, in The Central Nervous System (O. T. Bailey and D. E. Smith, eds.) Chap. 10, pp. 201–208, Williams and Wilkins, Baltimore (1968).
L. T. Heston, D. L. W. Lowther, and C. M. Leventhal, Alzheimer’s disease, Arch. Neurol. 15: 225–233 (1966).
R. G. Feldman, K. A. Chandler, L. L. Levy, and G. H. Glaser, Familial Alzheimer’s disease, Neurology 13: 811–824 (1963).
M. Kidd, Alzheimer’s disease—an electron microscopical study, Brain 87: 307–320 (1964).
S. A. Luse and K. R. Smith, Jr., The ultrastructure of senile plaques, Am. J. Path. 44: 553–563 (1964).
R. D. Terry, N. K. Gonatas, and M. Weiss, Ultrastructural studies in Alzheimer’s presenile dementia, Amer. J. Path. 44: 269–282 (1964).
M. R. Krigman, R. G. Feldman, and K. Bensch, Alzheimer’s presenile dementia, Lab. Invest.14: 381–396 (1965).
N. K. Gonatas, W. Anderson, and I. Evangelista, The contribution of altered synapses in the senile plaque: an electron microscopic study in Alzheimer’s dementia, J. Neuropath. Exper. Neurol. 26: 25–39 (1967).
N. K. Gonatas, Neocortical synapses in a presenile dementia, J. Neuropath. Exper. Neurol. 26: 150–151 (1967).
K. Suzuki and R. D. Terry, Fine structural localization of acid phosphatase in senile plaques in Alzheimer’s presenile dementia, Acta Neuropath. 8: 276–284 (1967).
R. D. Terry, in The Central Nervous System (O. T. Bailey and D. E. Smith, eds.) Chap. 12, pp. 213–224, Williams and Wilkins, Baltimore (1968).
T. Simchowicz, Histologische Studien über die senile demenz, Histol. Histopath. Arb. Grosshirnrinde (Jena) 4: 267–444 (1911).
A. Pope, H. H. Hess, and E. Lewin, Microchemical pathology of the cerebral cortex in pre-senile dementias, Trans. Amer. Neurol. Assn. 89: 15–16 (1964).
A. Pope, H. H. Hess, and E. Lewin, in Morphological and Biochemical Correlates of Neural Activity (M. M. Cohen and R. S. Snider, eds.) pp. 98–111, Hoeber Medical Division, Harper and Row, New York (1964).
G. Rouser, C. Galli, and G. Kritchevsky, Lipid class composition of normal human brain and variations in metachromatic leucodystrophy, Tay-Sachs, Niemann-Pick, chronic Gaucher’s and Alzheimer’s disease, J. Amer. Oil Chemists’ Soc. 42: 404–410 (1965).
K. Suzuki, R. Katzman, and S. R. Korey, Chemical studies on Alzheimer’s disease, J. Neuropath. Exper. Neurol 24: 211–224 (1965).
K. Suzuki and G. Chen, Chemical studies on Jakob-Creutzfeldt disease, J. Neuropath. Exper. Neurol. 25: 396–408 (1966).
G. Rouser, G. Feldman, and C. Galli, Fatty acid composition of human brain lecithin and sphingomyelin in normal individuals, senile cerebral cortical atrophy, Alzheimer’s disease, metachromatic leucodystrophy, Tay-Sachs and Niemann-Pick diseases, J. Amer. Oil Chemists’ Soc. 42: 411–412 (1965).
G. Rouser, G. Kritchevsky, and C. Galli, Speculations on the nature of the metabolic defects in Tay-Sachs, Niemann-Pick, Gaucher’s and Alzheimer’s diseases and metachromatic leucodystrophy, J. Amer. Oil Chemists’ Soc. 42: 412–416 (1965).
G. Rouser and A. Yamamoto, in Handbook of Neurochemistry (A. Lajtha, ed.) Vol. I, Ch. 8, pp. 121–169, Plenum Press, New York (1969).
G. D. Cherayil, Estimation of glycolipids in four selected lobes of human brain in neurological diseases, J. Neurochem. 16: 913–920 (1969).
G. D. Cherayil, Fatty acid composition of brain glycolipids in Alzheimer’s disease, senile dementia, and cerebrocortical atrophy, J. Lipid Res. 9: 207–214 (1968).
G. D. Cherayil and A. E. Cyrus, The quantitative estimation of glycolipids in Alzheimer’s disease, J. Neurochem. 13: 579–590 (1966).
S. A. Korey, L. Scheinberg, R. Terry, and A. Stein, Studies in presenile dementia, Trans. Amer. Neurol. Assn. 86: 99–102 (1961).
R. Katzman and K. Suzuki, A search for a chemical correlate of amyloid in senile plaques of Alzheimer’s disease, Trans. Amer. Neurol. Assn. 89: 17–20 (1964).
C. G. Gottfries, I. Gottfries, and B. E. Roos, in The Present Status of Psychotropic Drugs: Proc. of the Internat. Cong, of the Coll. Internat. Neuro-Psychopharmacologicum (A. Cerletti and F. J. Bové, eds.) Ex. Med. Int. Cong. Ser. 180, pp. 310–312, 6th ed., Tarragona, Amsterdam (1969).
C. G. Gottfries, I. Gottfries, and B. E. Roos, Homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid of patients with senile dementia, presenile dementia, and parkinsonism, J. Neurochem. 16: 1341–1345 (1969).
L. Goodman, Alzheimer’s disease, a clinico-pathologic analysis of twenty-three cases with a theory on pathogenesis, J. Nerv, and Ment. Dis. 117: 97–130 (1953).
B. Hallgren and P. Sourander, The non-haemin iron in the cerebral cortex in Alzheimer’s disease, J. Neurochem. 5: 307–310 (1960).
K. Suzuki, S. R. Korey, and R. D. Terry, Studies on protein synthesis in brain microsomal system, J. Neurochem. 11: 403–412 (1964).
L. J. Embree and H. H. Hess, in Second International Meeting of the International Society for Neurochemistry (R. Paoletti, R. Fumagalli, and G. Galli, eds.) pp. 162, Tamburini Editore, Milano (1969).
L. J. Embree and H. H. Hess, Microchemistry of ATPases in normal and Alzheimer’s disease cortex, J. Neuropath. Exper. Neurol. 29: 136–137 (1970).
W. D. Obrist, E. Chivian, S. Cronqvist, and D. H. Ingvar, Regional cerebral blood flow in senile and presenile dementia, Neurology 20: 315–322 (1970).
N. A. Lassen, O. Munck, and E. R. Tottey, Mental function and cerebral oxygen consumption in organic dementia, Arch. Neurol. and Psychiat. 77: 126–133 (1957).
C. W. M. Adams, in Neurohistochemistry (C. W. M. Adams, ed.) pp. 414–416, Elsivier Publishing Co., Amsterdam (1965).
G. Margolis and J. P. Pickett, Senile cerebral disease, Lab. Invest. 8: 335–370 (1959).
F. Morel and E. Wildi, in Proceedings of the First International Congress of Neuropathology, Rome, 1952, Vol. 2, pp. 347–374, Rosenberg and Sellier, Turin (1955).
G. Margolis, Observations on senile cerebral deposits using the periodic acid-Schiff’s technic, Amer. J. Path. 29: 588 (1953).
P. Divry, Etude histo-chemique des plaques seniles, J. Neurol. Psychiat. 27: 643–657 (1927).
P. Divry, De 1a nature de l’altération fibrillaire d’Alzheimer, J. Neurol. Psychiat. 34: 197–201 (1934).
R. L. Friede and K. R. Magee, Alzheimer’s disease, Neurology 12: 213–222 (1962).
R. L. Friede, Enzyme histochemical studies of senile plaques, J. Neuropath. Exper. Neurol. 24: 477–4191 (1965).
H. Josephy, Acid phosphatase in the senile brain, Arch. Neurol. Psychiat. Chicago) 61: 164–169 (1949).
A. B. Johnson, Apparent nucleoside phosphatase activity in the neurofibrillary tangles of Alzheimer’s disease, J. Neuropath. Exper. Neurol. 27: 155–156 (1968).
W. H. McMenemey, in Greenfield’s Neuropathology (W. Blackwood, W. H. McMenemey, A. Meyer, R. M. Norman, and D. S. Russell, eds.) Ch. 9, p. 576, Williams and Wilkins, Baltimore (1963).
C. G. Gottfries, I. Gottfries, and B. E. Roos, The investigation of homovanillic acid in the human brain and its correlation to senile dementia, Brit. J. Psychiat. 115: 563–574 (1969).
F. A. Freyhan, R. B. Woodford, and S. S. Kety, Cerebral blood flow and metabolism in psychoses of senility, J. Nerv. Ment. Dis. 113: 449–456 (1951).
N. A. Lassen, I. Feinberg, and H. M. Lane, Bilateral studies of cerebral oxygen uptake in young and aged normal subjects and in patients with organic dementia, J. Clin. Invest. 39: 491-500 (1960).
S. Hedlund, V. Köhler, G. Nylin, R. Olsson, O. Regnström, E. Rothström, and K.-E. Åstrom, Cerebral blood circulation in dementia, Acta Psychiat. Scand. 40: 77–106 (1964).
L. Sololoff, in Cerebrovascular Disease, Res. Publ. Assn. Nerv. Ment. Dis. (C. H. Millikan, éd.) Vol. 41, pp. 237–251, Williams and Wilkins Co.,Baltimore (196
F. C. Stam, in Proc. Fifth Inter. Cong. Neuropath. (F. Luthy and A. Bischoff, eds.) Inter. Cong. Ser. 100, pp. 513–517, Excerpta Medica Foundation (1966).
H. Wisniewski, R. D. Terry, C. Peña, E. Streicher, and I. Klatzo, Experimental production of neurofibrillary degeneration, J. Neuropath. Exper. Neurol. 24: 139 (1965).
I. Klatzo, H. Wisniewski, and E. Streicher, Experimental production of neurofibrillary degeneration. I. Light microscopic observations, J. Neuropath. Exper. Neurol. 24: 187–199 (1965).
R. D. Terry and C. Peña, Experimental production of neurofibrillary degeneration. 2. Electron microscopy, phosphatase histochemistry and electron probe analysis, J. Neuropath. Exper. Neurol. 24: 200–210 (1965).
I. Klatzo, in The Central Nervous System (O. T. Bailey and D. E. Smith, eds.) Chap. 11, pp. 209–212, Williams and Wilkins, Baltimore (1968).
H. Wisniewski and R. D. Terry, Further studies on experimental neurofibrillary tangles, J. Neuropath. Exper. Neurol. 27: 149 (1968).
H. Wisniewski, W. Karczewski, and K. Wisniewski, Neurofibrillary degeneration of nerve cells after intracerebral injection of aluminium cream, Acta Neuropath. 6: 211–219 (1966).
F. J. Seil, P. W. Lampert, and I. Klatzo, Neurofibrillary spheroids induced by aluminum phosphate in dorsal root ganglia neurons in vitro, J. Neuropath. Exper. Neurol. 28: 74–85 (1969).
L. J. Embree, A. Hamberger, and J. Sjöstrand, Quantitative cytochemical studies and histochemistry in experimental neurofibrillary degeneration, J. Neuropath. Exper. Neurol. 26: 427–436 (1967).
L. J. Embree, Ribonucleic acid in experimental neurofibrillary degeneration studied by quantitative cytochemical methods, J. Neuropath. Exper. Neurol. 27: 148–149 (1968).
G. D. Cherayil and A. E. Cyrus, in Second International Meeting of the International Society for Neurochemistry (R. Paoletti, R. Fumagalli, and G. Falli, eds.) p. 124, Tamburini Editore, Milano (1969).
R. E. Exss and G. K. Summer, Effect of aluminum phosphate on neuraminic acid concentration in rabbit brain, Fed. Proc. 28: 480 (1969).
H. A. Hartmann, J. J. Lalich, and K. Akert, Lesions in the anterior motor horn cells of rats after administration of bis-b-cyanoethylamine, J. Neuropath. Exper. Neurol. 17: 298–304 (1958).
G. Ule, Zur Ultrastruktur der ghost-cells beim experimentellen neurolathyrismus der ratte, Z. Zellforsch. 56: 130–142 (1962).
S. M. Chou and H. Hartmann, Electron microscopy of focal neuroaxonal lesions produced by β-β’-iminodipropionitrile (IDPN) in rats, Acta Neuropath. 4: 590–603 (1965).
P. B. Diezel and G. Ule, Histochemische Untersuchungen an den “ghost cells” beim experimentellen neurolathyrismus, Acta Neuropath. 3: 150–163 (1963).
H. A. Hartmann, J.-E. Edström, and H. Hydén, Weight, volume and ribonucleic acid content of nerve cells in rats made hyperactive with iminodipropionitrile, Fed. Proc. 18: 480 (1959).
D. E. Slagel, H. A. Hartmann, and J.-E. Edström, The effect of iminodipropionitrile on the ribonucleic acid content and composition of mesencephalic V cells, anterior horn cells, glial cells and axonal balloons, J. Neuropath. Exper. Neurol. 25: 244–253 (1966).
H. A. Hartmann and M. C. Casapis, Cytoplasmic and axoplasmic density variations in relation to hyperactivity, Acta Neuropath. 7: 327–335 (1967).
J.-E. Edström, Quantitative determination of ribonucleic acid in the micromicrogram range, J. Neurochem. 3: 100–106 (1958).
J.-E. Edström, Extraction, hydrolysis and electrophoretic analysis of ribonucleic acid from microscopic tissue units (microphoresis), J. Biophys. Biochem. Cytol. 8: 39–43 (1960).
A. Edström. The ribonucleic acid in the Mauthner neuron of the goldfish, J. Neurochem. 11: 309–314 (1964).
J.-E. Edström, D. Eichner, and A. Edström, The ribonucleic acid of axons and myelin sheaths from Mauthner neurons, Biochem. Biophys. Acta 61: 178–184 (1962).
H. A. Hartmann, J. Lin, and M. C. Shively, RNA of nerve cell bodies and axons after β, β-iminodipropionitrile, Acta Neuropath. 11: 275–281 (1968).
H. A. Hartmann and J. Lin, Nuclear and cytoplasmic RNA in experimental neuroaxonal dystrophy, J. Neuropath. Exper. Neurol. 29: 135 (1970).
N. A. Schor and H. A. Hartmann, NADPH generating enzymes after β-β iminodipropionitrile, J. Neuropath. Exper. Neurol. 28: 168 (1969).
E. R. Peterson and M. R. Murray, Serial observations in tissue cultures on neurotoxic effects of colchicine, Anat. Record 154: 401 (1966).
E. R. Peterson and M. B. Bornstein, The neurotoxic effects of colchicine on tissue cultures of cord-ganglia, J. Neuropath. Exper. Neurol. 27: 121–122 (1968).
E. R. Peterson, Neurofibrillar alterations in cord-ganglion cultures exposed to spindle inhibitors, J. Neuropath. Exper. Neurol. 28: 168 (1969).
R. P. Bunge and M. B. Bunge, A comparison of neuronal changes following colchicine treatment with observations on other conditions involving the accumulation of neurofilaments, J. Neuropath. Exper. Neurol. 28: 169 (1969).
F. J. Seil and P. W. Lampert, Neurofibrillary tangles induced by vincristine and vinblastine sulfate in central and peripheral neurons in vitro, Exper. Neurol. 21: 219–230 (1968).
W. Schlaepfer, In vitro alterations of neurotubules and neurofilaments in rat peripheral nerve, Fed. Proc. 29: 290 (1970).
H. Wisniewski and R. D. Terry, Experimental colchicine encephalopathy. I. Introduction of neurofibrillary tangles, Lab. Invest. 17: 577–587 (1967).
H. Wisniewski, M. L. Shelanski, and R. D. Terry, Effects of mitotic spindle inhibitors on neurotubules and neurofilaments in anterior horn cells, J. Cell Biol. 38: 224–229 (1968).
H. Wisniewski, R. D. Terry, and M. L. Shelanski, Neurofibrillary degeneration of nerve cells after subarachnoid injection of mitotic spindle inhibitors, J. Neuropath. Exper. Neurol. 28: 168 (1969).
G. G. Borisy and E. W. Taylor, The mechanism of action of colchicine: binding of colchicine-3H to cellular protein, J. Cell Biol. 34: 525–533 (1967).
G. G. Borisy and E. W. Taylor, The mechanism of action of colchicine: colchicine binding to sea urchin eggs and the mitotic apparatus, J. Cell. Biol. 34: 535–548 (1967).
M. L. Shelanski and E. W. Taylor, Isolation of a protein subunit from microtubules, J. Cell Biol. 34: 549–554 (1967).
M. L. Shelanski and E. W. Taylor, Properties of the protein subunit of central-pair and outer-doublet microtubules of sea urchin flagella, J. Cell. Biol. 38: 304–306 (1968).
M. Ventilla, C. R. Cantor, and M. Shelanski, Vinblastine effect on GTP binding to microtubule protein, Fed. Proc. 29: 290 (1970).
R. C. Weisenberg, G. G. Borisy, and E. W. Taylor, The colchicine-binding protein of mammalian brain and its relation to microtubules, Biochemistry 7: 4466–4479 (1968).
F. L. Renaud, A. J. Rowe, and I. R. Gibbons, Some properties of the protein forming the outer fibers of cilia, J. Cell. Biol 36: 79–90 (1968).
S. Puszkin, S. Berl, E. Puszkin, and D. D. Clark, Actomyosin-like protein isolated from mammalian brain, Science 161: 170–171 (1968).
S. Berl and S. Puszkin in Second International Meeting of the International Society for Neurochemistry (R. Paoletti, R. Fumagalli, and G. Galli, eds.) pp. 87–88, Tamurini Editore, Milano (1969).
F. O. Schmitt, Fibrous proteins—neuronal organelles, Proc. Nat. Acad. Sci. (U.S.) 60: 1092–1101 (1968); Neurosci. Res. Program Bull. 60:38-47 (1968).
J. Karlsson and J. Sjöstrand, The effect of colchicine on the axonal transport of protein in the optic nerve and tract of the rabbit, Brain Res. 13: 617–619 (1969).
W. W. Schlaepfer, Histochemical and structural changes in peripheral nerve following local injections of vincristine sulfate, J. Neuropath. Exper. Neurol. 29: 140–141 (1970).
M. R. Adelman, G. G. Borisy, M. L. Shelanski, R. C. Weisenberg, and E. W. Taylor, Cytoplasmic filaments and tubules, Fed. Proc. 27: 1186–1193 (1968).
F. O. Schmitt and F. E. Samson, Jr., Neuronal fibrous proteins, Neurosciences Res. Prog. Bull. 6: 113–219 (1968).
K. M. G. Keddie, Presenile dementia, clinically of the Pick’s disease variety, occurring in a mother and daughter, Int. J. Neuropsychiat. 3: 182–187 (1967).
A. Alzheimer, Über eigenartige krankheitsfalle des späteren alters, Z. Ges. Neurol. Psychiat. 4: 356–385 (1911).
S. S. Schochet, Jr., P. W. Lampert, and R. Lindberg, Fine structure of the Pick and Hirano bodies in a case of Pick’s disease, Acta Neuropath., 11: 330–337 (1968).
N. B. Rewcastle and M. J. Ball, Electron microscopic structure of the “inclusion bodies” in Pick’s disease, Neurology 18, 1205–1213 (1968).
L. Roizin, M. A. Kaufman, R. Wharton, R. Houspian, S. Keoseian, and J. C. Liu, Unusual histochemical and electron microscope findings in a cerebral biopsy of Pick’s psychosis, J. Neuropath. Exper. Neurol. 28: 153–154 (1969).
G. Huntington, On chorea, Med. Surg. Rep. (Philadelphia) 26: 317–321 (1872).
E. Slater, in Biochemical Aspects of Neurological Disorders (J.N. Cumings and M. Kremer, eds.) Chap. 17, pp. 271–285, F. A. Davis Co., Philadelphia (1965).
N. C. Myrianthopoulos, Huntington’s chorea, J. Med. Genet. 3: 298–314 (1966).
P. F. Borri and G. J. M. Hooghwinkle, Biochemical changes in heredo-degenerative diseases, in Proc. Fifth Inter. Cong. Neuropath. (F. Luthy and A. Bischoff, eds.) Inter. Cong. Ser. 100, pp. 437–444, Excerpta Medica Foundation (1966).
P. F. Borri, W. M. Opden Velde, G. J. M. Hooghwinkel, and G. W. Bruyn, Biochemical studies in Huntington’s chorea. VI. Composition of striatal neutral lipids, phospholipids, glycolipids, fatty acids, and amino acids, Neurology 17: 172–178 (1967).
G. J. M. Hooghwinkel, G. W. Bruyn, and R. E. de Rooy, Biochemical studies in Huntington’s chorea. VII. The lipid composition of the cerebral white and gray matter, Neurology 18: 408–412 (1968).
H. Hydén, Cellular chemistry of cerebral biopsies, in Proc. Fifth Inter. Cong. Neuropath., (F. Luthy and A. Bischoff, eds.) Inter. Cong. Ser. 100, pp. 382–388, Excerpta Medica Foundation (1966).
W. H. McMenemey, Immunity mechanisms in neurological disease, Proc. Roy. Soc. Med. 54: 127–136 (1961).
G. W. Bruyn, R. M. Lequin, Huntington’s chorea, Lancet 2: 1300 (1964).
J. R. Shawver, T. V. Frank, and S. M. Tranowski, Biochemical findings in Huntington’s chorea, Amer. J. Psychiat. 120: 1108 (1964).
V. C. Cowie and D. B. Gammack, Serum proteins in Huntington’s chorea, Brit. J. Psychiat. 112: 723–726 (1966).
H. Oepen and I. Oepen, Aminosäuren des blutes bei Huntingtonscher chorea, Humangenetik 1: 299–302 (1965).
G. W. Bruyn, Biochemical studies in Huntington’s chorea. Part 3. Aminoacids in serum and urine, Psychiat. Neurol. Neurochir. 69: 139–142 (1966).
J. Bruck, F. Gerstenbrand, H. Gnad, E. Gründig, and P. Prosenz, Ueber Veranderungen der Zusammensetzung des liquor cerebrospinalis beim choreatischen syndrom, J. Neurol. Sci. 5: 257–265 (1967).
T. L. Perry, S. Diamond, S. Hansen, and D. Stedman, Plasma-amino-acid levels in Huntington’s chorea, Lancet 1: 806–808 (1969).
H. Oepen and F. H. Kreutz, Orientierende Untersuchung des fettstoffwechsels bei Huntingtonscher chorea, Humangenetik 1: 101–102 (1964).
G. J. M. Hooghwinkel, P. F. Borri, and G. W. Bruyn, Biochemical studies in Huntington’s chorea. II. Composition of blood lipids, Acta Neurol. Scand. 42: 213–220 (1966).
J. R. Wherrett and B. L. Brown, Erythrocyte glycolipids in Huntington’s chorea, Neurology 19: 489–493 (1969).
P. F. Borri, G. J. M. Hooghwinkel, and G. W. Bruyn, Biochemical studies in Huntington’s chorea, Part 4. The fatty acid composition of plasma and erythrocyte lipids, Psychiat. Neurol. Neurochi. 69, 143–148 (1966).
G. J. M. Hooghwinkel, P. F. Borri, and G. W. Bruyn, Biochemical studies in Huntington’s chorea. V. Erythrocyte and plasma glycolipids and fatty acid composition of erythrocyte gangliosides, Neurology 16: 934–936 (1966).
H. J. Deiwick and H. Oepen, Hauptkettenenzyme im serum bei Huntingtonscher chorea, Humangenetik 1: 103–104 (1964).
A. Delbrück and H. Oepen, Mucopolysaccharidstoffwechsel bei Huntingtonscher chorea, Humangenetik 1: 105–106 (1964).
F. E. Kenyon and S. M. Hardy, A biochemical study of Huntington’s chorea, J. Neurol. Neurosurg. Psychiat. 26: 123–126 (1963).
G. W. Bruyn, C. J. K. Mink, and J. F. Caljé, Biochemical studies in Huntington’s chorea, erythrocyte magnesium, Neurology 15: 455–461 (1965).
M. T. Haslam, Cellular magnesium levels and the use of penicillamine in the treatment of Huntington’s chorea, J. Neurol. Neurosurg. Psychiat. 30: 185–188 (1967).
L. W. Fleming, M. G. Barker, and W. K. Stewart, Plasma and erythrocyte magnesium in Huntington’s chorea, J. Neurol. Neurosurg. Psychiat. 30: 374–378 (1967).
J. E. Jones, P. C. Desper, and E. B. Flink, Magnesium metabolism in Huntington’s chorea, Metabolism 14: 813–818 (1965).
C. B. Courville, R. E. Nusbaum, and E. M. Butt, Changes in trace metals in brain in Huntington’s chorea, Arch. Neurol. 8: 481–489 (1963).
J. N. Cumings, Trace elements in the brain in health and in neurological disease, Sci. Basis Med. Ann. Rev., pp. 35–57 (1965).
G. K. Klintworth, in Second International Congress of Neuro-genetics and Neuroophthalmology of the World Federation of Neurology, Montreal, September 1967. Abstr. 86, Int. Cong. Series 154, pp. 42, Excerpta Medica Foundation, Amsterdam (1967).
T. L. Perry, Urinary excretion of trace metals in Huntington’s chorea, Neurology 11: 1086–1090 (1961).
A. Barbeau, Preliminary observations on abnormal catecholamine metabolism in basal ganglia diseases, Neurology 10: 446–451 (1960).
A. Barbeau, Dopamine and basal ganglia diseases, Arch. Neurol. 4: 97–102 (1961).
D. K. Lee, C. H. Markham, and W. G. Clark, in Second International Congress of Neurogenetics and Neuro-ophthalmology of the World Federation of Neurology, Montreal, September 1967. Abstr. 86, Int. Cong. Series 154, pp. 41–42, Excerpta Medica Foundation, Amsterdam (1967).
C. M. Williams, S. Maury, and R. F. Kibler, Normal excretion of homovanillic acid in the urine of patients with Huntington’s chorea, J. Neurochem. 6: 254–256 (1961).
T. L. Sourkes, D. Pivnicki, W. T. Brown, M. H. Wisemandistler, G. F. Murphy, I. Sankoff, and S. Saint Cyr, A clinical and metabolic study of dopa (3,4-dihydroxyphenylalanine) and methyldopa in Huntington’s chorea, Psychiat. Neurol., Basel 149: 7–27 (1965).
J. Mills, A. Orr, and J. R. Whittier, Huntington’s chorea: Differentiation of brain tissue from non-hereditary degenerative disease by infrared spectra, J. Neurochem. 16: 1033–1035 (1969).
G. Creutzfeldt, Über eine eigenartige herdförmige erkrankung des Zentralnervensystems, Z. Ges. Neurol. Psychiat. 57: 1–18 (1920).
A. Jakob, Über eigenartige erkrankungen des zentralnerven-systems mit bemarkenswerten anatomischen befunde, Z. Ges. Neurol. Psychiat. 64: 147–228 (1921).
W. W. May, Creutzfeldt-Jakob disease: I. Survey of the literature and clinical diagnosis, Acta Neurol. Scand. 44: 1–32 (1968).
H. Siedler and N. Malamud, Creutzfeldt-Jakob disease: Clinicopathologic report of fifteen cases and review of the literature (with special reference to a related disorder designated as subacute spongioform encephalopathy), J. Neuropath. Exper. Neurol. 22: 381–402 (1963).
S. Nevin, W. H. McMenemey, S. Behrman, and D. P. Jones, Subacute spongioform encephalopathy: a subacute form of encephalopathy attributable to vascular dysfunction (spongioform cerebral atrophy), Brain 83: 519–564 (1960).
W. R. Kirschbaum, Jakob-Creutzfeldt Disease, American Elsevier Publishing Co., New York (1968).
W. M. May, H. H. Itabashi, and R. N. De Jong, Creutzfeldt-Jakob disease: II. Clinical, pathologic, and genetic study of a family, Arch. Neurol. 19: 137–149 (1968).
C. M. Fisher, The clinical picture in Creutzfeldt-Jakob disease, Trans. Amer. Neurol. Assn.85: 147–150 (1960).
R. Katzman, E. H. Kagan, and H. M. Zimmerman, A case of Jakob-Creutzfeldt Disease, 1. Clinicopathological analysis, J. Neuropath. Exper. Neurol. 20: 78–94 (1961).
S. Bornstein and G. A. Jervis, Presenile dementia of the Jakob type (cortico-striospinal degeneration), Arch. Neurol. Psychiat. 74: 598–610 (1955).
E. Christensen and A. Brun, Subacute spongioform encephalopathy: spongioform cerebral atrophy, Neurology (Minneap.) 13: 455–463 (1963).
M. R. Crompton, A case of subacute spongioform encephalopathy supporting a vascular pathogenesis, Acta Neuropath. (Berlin) 2: 291–296 (1963).
W. H. McMenemey, A critical review: dementia in middle age, J. Neurol. Psychiat. 4: 38–79 (1941).
J. M. Foley and D. Denny-Brown, Subacute progressive encephalopathy with bulbar myoclonus, J. Neuropath Exper. Neurol. 16: 133–136 (1957).
J. H. Silberman, H. Cravioto, and I. Feigin, I. Corticostriatal degeneration of the Creutzfeldt-Jakob type, J. Neuropath Exper. Neurol. 20: 105–118 (1961).
N. H. Bass, H. H. Hess, and A. Pope, Microchemical pathology of cerebral cortex in Creutzfeldt-Jakob disease, Trans. Amer. Neurol. Assn. 93: 108–110 (1968).
S. R. Korey, R. Katzman, and J. Orloff, A case of Jakob-Creutzfeldt disease: 2. Analysis of some constituents of the brain of a patient with Jakob-Creutzfeldt disease, J. Neuropath Exper. Neurol. 20: 95–104 (1961).
J. Folch-Pi, The composition of nervous membranes, Progr. in Brain Res. 29: 1–17 (1968).
N. K. Gonatas, R. D. Terry, and M. Weiss, Electron microscopic study in two cases of Jakob-Creutzfeldt disease, J. Neuropath. Exper. Neurol 24: 575–598 (1965).
J. Abbott, The EEG in Jakob-Creutzfeldt’s disease, Electroenceph. Clin. Neurophysiol. 11: 184–185 (1959).
M. Rayport, Electroencephalographic, corticographic and intracerebral potentials in two anatomically verified cases of Creutzfeldt-Jakob disease, Electroenceph. Clin. Neurophysiol. 15: 922 (1963).
Y. Kishimoto, N. S. Radin, W. W. Tourtellotte, J. A. Parker, and H. H. Itabashi, Gangliosides and glycerophospholipids in multiple sclerosis white matter, Arch. Neurol. 16: 44–54 (1967).
L. J. Embree, H. H. Hess, and H. M. Shein, Biochemical structural components of cloned N-nitrosomethylurea-induced astrocytomas grown subcutaneously, Neurology 19: 299 (1969).
H. H. Hess, L. J. Embree, and H. M. Shein, in Second Meeting Intern. Soc. for Neurochem., pp. 42–43, Tamburini Editore, Milano (1969).
O. Marin and J. D. Vial, Neuropathological and ultrastructural findings in two cases of subacute spongioform encephalopathy, Acta Neuropath. (Berlin) 4: 218–229 (1964).
J. F. Foncin, J. Gashes, and J. Le Beau, Encephalopathie spongioforme (apparentée a la maladie de Creutzfeldt-Jakob): biopsie étudiée au microscope électronique confirmation autopsique, Rev. Neurol. (Paris) 111: 507–515 (1964).
G. L. Guazzi and F. Seitelberger, Symposium on presenile spongy encephalopathies, Acta Neuropath. Suppl. III, pp. 1–152 (1967).
R. L. Friede and R. N. De Jong, Neuronal enzymatic failure in Creutzfeldt-Jakob disease: A familial study, Arch. Neurol. 10: 181–195 (1964).
N. Robinson, Creutzfeldt-Jakob’s disease: a histochemical study, Brain 92: 581–588 (1969).
A. Hirano, L. T. Kurland, R. S. Krooth, and S. Lessell, Parkinsonism-dementia complex, an endemic disease on the island of Guam. I. Clinical features, Brain 84: 642–661 (1961).
I. Klatzo, D. C. Gadjusek, and V. Zigas, Pathology of kuru, Lab. Invest. 8: 799–847 (1959).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1972 Plenum Press, New York
About this chapter
Cite this chapter
Embree, L.J., Bass, N.H., Pope, A. (1972). Biochemistry of Middle and Late Life Dementias. In: Lajtha, A. (eds) Handbook of Neurochemistry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-7172-8_15
Download citation
DOI: https://doi.org/10.1007/978-1-4615-7172-8_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-7174-2
Online ISBN: 978-1-4615-7172-8
eBook Packages: Springer Book Archive